- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02090777
Health Coaching for Glaucoma Patients
February 17, 2016 updated by: Duke University
Health Coaching for Glaucoma Patients, Pilot Study
The study will be conducted to examine the feasibility of using a Health Coach for improving the ophthalmic care of glaucoma patients.
Patients taking glaucoma medications will have a coaching intervention and adherence to glaucoma drops will be monitored using a dose-recording device.
The dosing data will be analyzed to examine the effect on adherence and qualitative interviews at the conclusion of the study will be used to examine which elements of the coaching experience were most helpful in the glaucoma patient population.
Study Overview
Detailed Description
Glaucoma medication adherence will be tracked using a dose recording device to record eye drop usage.
Study Type
Interventional
Enrollment (Actual)
9
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27710
- Duke Eye Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adult whose age is >18 years
- Diagnosed with glaucoma
- Patient of Duke Glaucoma Service
- Prescribed or using topical glaucoma eye medication for at least 6 months
- Primarily self-administering his or her eye drops
- English speaking
- Patient should be able to use the telephone for the coaching intervention,
- Patient should be available by phone to complete the coaching intervention
- Patient should be willing and able to use the MEMS (Medication Event Monitoring System) device for recording medication use
- Patient must be willing and able to come to the Eye Center for an exit interview and to return the MEMS device
- Patient must be able to give consent
Exclusion Criteria:
- Patient should be excluded if he or she may need glaucoma surgery or laser during the 6 months of the study period
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Health Coach
Health Coach is conducted to see if it improves ophthalmic care for glaucoma patients.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Glaucoma Medication Adherence
Time Frame: 6 Months
|
Glaucoma medication adherence will be tracked using a dose recording device to record eye drop usage.
The average of the participants percentage of time they adhered to using the medication will be reported.
|
6 Months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jullia Rosdahl, MD, PhD, Duke University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2014
Primary Completion (Actual)
April 1, 2015
Study Completion (Actual)
April 1, 2015
Study Registration Dates
First Submitted
March 14, 2014
First Submitted That Met QC Criteria
March 14, 2014
First Posted (Estimate)
March 18, 2014
Study Record Updates
Last Update Posted (Estimate)
March 14, 2016
Last Update Submitted That Met QC Criteria
February 17, 2016
Last Verified
January 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro00052498
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Glaucoma
-
Hospices Civils de LyonRecruitingOpen-angle Glaucoma | Glaucoma Eye | Pigmentary Glaucoma | Closed-Angle Glaucoma | Pseudo Exfoliative SyndromeFrance
-
Imperial College Healthcare NHS TrustIRIDEX CorporationNot yet recruitingGlaucoma | Glaucoma, Open-Angle | Glaucoma, Angle-Closure | Glaucoma, Neovascular | Glaucoma Eye | Glaucoma Secondary | Glaucoma Traumatic | Glaucoma Uveitic
-
Wills EyeIOP OphthalmicsTerminatedPrimary Open Angle Glaucoma | Neovascular Glaucoma | Uveitic Glaucoma | Pseudoexfoliation Glaucoma | Primary Angle Closure Glaucoma | Pigmentary Glaucoma | Traumatic GlaucomaUnited States
-
University of MiamiAbbVieRecruitingOcular Hypertension | Glaucoma | Open-Angle Glaucoma | Glaucoma SuspectUnited States
-
Ngoc Nguyen Inc.Alcon ResearchNot yet recruitingGlaucoma | Glaucoma, Open Angle | Open Angle Glaucoma (OAG) | Normal Tension Glaucoma (NTG)United States
-
Isfahan University of Medical SciencesActive, not recruitingAngle Closure Glaucoma | Glaucoma EyeIran
-
Centre hospitalier de l'Université de Montréal...CompletedGlaucoma | Glaucoma, Open-Angle | Glaucoma, Neovascular | Glaucoma Eye | Glaucoma and Ocular Hypertension | Glaucoma, Uncompensated | Glaucoma SecondaryCanada
-
Pro Top & Mediking Company LimitedCompletedOpen Angle Glaucoma | Neovascular Glaucoma | Angle Closure Glaucoma | Uveitis Glaucoma | Young Age Glaucoma | High Risk PatientEstonia
-
Henry Ford Health SystemNot yet recruitingPrimary Open Angle Glaucoma (POAG) | Secondary Open Angle Glaucoma | Open Angle Glaucoma (OAG)United States
-
Sanoculis LtdCompletedPrimary Open Angle Glaucoma | Pigmentary Glaucoma | Pseudoexfoliative GlaucomaIsrael
Clinical Trials on Health Coach
-
Dartmouth-Hitchcock Medical CenterPatient-Centered Outcomes Research Institute; Trustees of Dartmouth CollegeCompleted
-
Vanderbilt University Medical CenterRecruitingChildhood ObesityUnited States
-
Taipei Medical UniversityMinistry of Science and Technology, TaiwanCompleted
-
University of Texas Southwestern Medical CenterUnlocking DoorsRecruitingThe Unlocking PrEP Study: Integration of Peer Health Navigation Into Comprehensive Re-entry ServicesHIV Prevention | HIV DiseaseUnited States
-
Clinical Directors NetworkPatient-Centered Outcomes Research InstituteRecruitingSelf-Management | ComorbidityUnited States
-
Wake Forest University Health SciencesTerminatedEpilepsy | Refractory EpilepsyUnited States
-
Women's College HospitalRecruiting
-
Emory UniversityAmerican Heart AssociationCompletedCardiovascular DiseasesUnited States
-
University of VictoriaThe Lawson FoundationCompleted
-
Johns Hopkins UniversityNational Institute of Environmental Health Sciences (NIEHS); Environmental...Completed